DB Lecture Flashcards
criteria for impaired fasting glucose
HgbA1C between 5.7% and 6.4%
i. An autoimmune disease that destroys the pancreatic beta cells that results in the body not producing sufficient insulin
1) Requires exogenous insulin to survive
2) Usually does not present until about 90% of the beta cells have been destroyed
T1DM
ii. Faster onset usually in ages of 20 or younger
1) Usually a thin body habitus
2) Ketosis is very common
T1DM
i. Body is not responding to insulin
1) Have an over abundance of glucose and free fatty acid fail to stimulate the pancreas to secrete insulin
ii. Slower gradual onset in adults
1) Frequently obese
2) Rarely have ketosis
3) Risk factors: obesity (greatest risk factor), genetics, age (insulin production decreases with age)
T2DM
i. Body has a surge of hormones, growth hormone included, and the body cannot release insulin/respond with insulin sufficiently to respond to the increase in blood sugar
ii. See hyperglycemia in the morning and NO hypoglycemia through the night
iii. Management:
1) Increase evening insulin
Dawn phenomenon
i. Rebound response to nocturnal hypoglycemia that results in hyperglycemia in the AM
ii. Patient does have low sugars through the night
iii. Management:
1) Eat a snack before bed
2) Decrease evening insulin
Somogyi Effect
a. Symptoms + random glucose of > 200 mg/dL
b. Fasting plasma glucose of > 126 mg/dL on two separate occasions
c. Plasma glucose of > 200 mg/dL two hours after a 75-g glucose load during an oral glucose tolerance test
d. A1C > 6.5%
diagnostic criteria for diabetes mellitus
Other than the following sx, what are other common sx of DB?
i. Polydipsia
ii. Polyuria
iii. Polyphagia
iv. Fatigue
v. Weight loss
vi. Blurred vision
vii. Fungal infections
viii. Numbness, tingling of hands and feet
MCC of death in diabetic patients is
CAD
manifestations regarding macrovascular complications associated with diabetes mellitus
i. Main problem is accelerated atherosclerosis
1) Increased risk for stroke, MI, heart failure
2) Renal disease
ii. Increased peripheral vascular disease, cerebrovascular disease (strokes)
Macrovascular complications treatments in general
Smoking cessation, daily aspirin, BP control, lipid-lowering agents, strict glycemic control
MCC of end stage renal disease
Diabetic nephropathy
hyaline deposition in one area of the glomerulus —> pathognomonic for DM
Nodular glomerular sclerosis of Diabetic nephropathy
Screening test: Diabetic nephropathy
Microalbuminuria –> shows up in the urine about a year before you’ll find proteinuria on the dipstick
a) Usually see HTN develop between the microalbuminuria to proteinuria stages
Diabetic nephropathy Treatment
1) ACE-inhibitor or ARB –> renal protective as dilates the efferent arteriole of the glomerulus as well to prevent increased glomerular pressure and prevent spillage of proteins